TaggedH1Reactivation of tuberculosis after immunomodulatory treatment for severe SARS-CoV-2 infection
暂无分享,去创建一个
[1] K. DeGeorge,et al. Reactivation of latent tuberculosis in a COVID-19 patient on corticosteroid treatment , 2022, BMJ Case Reports.
[2] Peter J. Godolphin,et al. Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis. , 2021, JAMA.
[3] S. Subbian,et al. Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis , 2021, International journal of molecular sciences.
[4] P. Klenerman,et al. Risk of Reactivation of Hepatitis B Virus (HBV) and Tuberculosis (TB) and Complications of Hepatitis C Virus (HCV) Following Tocilizumab Therapy: A Systematic Review to Inform Risk Assessment in the COVID-19 Era , 2021, Frontiers in Medicine.
[5] M. Khayat,et al. COVID-19 promoting the development of active tuberculosis in a patient with latent tuberculosis infection: A case report , 2021, Respiratory Medicine Case Reports.
[6] M. Mantero,et al. Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy , 2020, Respiratory Medicine.
[7] Arthur S Slutsky,et al. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. , 2020, JAMA.
[8] S. Tavakolpour,et al. Lymphopenia during the COVID-19 infection: What it shows and what can be learned , 2020, Immunology Letters.
[9] R. Pranata,et al. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis , 2020, Journal of Intensive Care.
[10] J. Yim,et al. Use of inhaled corticosteroids and the risk of tuberculosis , 2013, Thorax.
[11] C. K. Kwan,et al. HIV and Tuberculosis: a Deadly Human Syndemic , 2011, Clinical Microbiology Reviews.
[12] F. Cobelens,et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement , 2009, European Respiratory Journal.
[13] Mahboob Rahman,et al. Glucocorticoid use, other associated factors, and the risk of tuberculosis. , 2006, Arthritis and rheumatism.
[14] P. Grenier,et al. Pulmonary tuberculosis: comparison of CT findings in HIV-seropositive and HIV-seronegative patients. , 1996, Radiology.